Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Observational Study
. 2024 Nov 10;14(1):27447.
doi: 10.1038/s41598-024-65643-8.

Diuretics and mortality reduction in incident dialysis patients: a two-year observational study

Affiliations
Observational Study

Diuretics and mortality reduction in incident dialysis patients: a two-year observational study

Maxime Ingwiller et al. Sci Rep. .

Abstract

Fluid overload predicts morbidity and mortality in dialysis patients. Diuretics can reduce fluid overload, but their effects on morbi-mortality following inception remain ill-defined. To determine whether diuretics reduce mortality and hospitalization rates in incident dialysis patients in the first 2 years after inception. Adult patients starting dialysis between 2009 and 2015 in the REIN registry were matched with the SNDS database and divided into four subgroups according to loop diuretics exposure: < 5%, 5-50%, 50-80% or > 80% over the observation period of each patient. The incidence of hospitalization was described based on the primary diagnoses of the discharge summaries and codes. In this study, which included 67,736 patients, 53,829 (79.5%) who had varying degrees of diuretic exposure exhibited a significantly lower mortality rate at 2 years compared to those without diuretic exposure (24.8% [95% CI 24.4-25.2], vs 37.5% [95% CI 36.7-38.3] respectively). However, the duration of diuretic exposure significantly impacted outcomes. The all-cause mortality rate at two years was highest in the group with ≥ 80% exposure (68.2% [95% CI 67.3-69.1]), followed by those with 50-80% exposure (15.7% [95% CI 15.0-16.4]), and those with 5-50% exposure (6.6% [95% CI 6.3-7.0]). An inverse probability weighting (IPW) propensity score analysis supported these findings. Stratified analyses showed consistent results regardless of a history of congestive heart failure and were similar for both hemodialysis and peritoneal dialysis patients. Additionally, the number of hospitalizations and length of stay were generally higher in the group with the longest exposure to loop diuretics. Diuretic exposure was generally associated with a lower mortality rate in dialysis patients. However, prolonged exposure (≥ 80%) was linked to an increased risk of mortality and hospitalization. This prolonged exposure may indicate residual diuresis at the cost of chronic fluid overload.

Keywords: Chronic dialysis; Fluid overload; Hemodialysis; Loop diuretics; Peritoneal dialysis; Survival.

PubMed Disclaimer

Conflict of interest statement

Competing interests The authors declare no competing interests.

Figures

Figure 1
Figure 1
IPW-adjusted cumulative incidence (and 95% confidence interval) of all-cause death, according to loop diuretic exposure or not.
Figure 2
Figure 2
IPW-adjusted cumulative incidence (and 95% confidence interval) of death after inception, according to the duration of loop diuretic exposure.
Figure 3
Figure 3
IPW-adjusted cumulative incidence (and 95% confidence interval) of death after inception according to the duration of loop diuretic exposure, stratified for dialysis modality.
Figure 4
Figure 4
IPW-adjusted cumulative incidence (and 95% confidence interval) of death after inception, according to the duration of loop diuretic exposure, stratified for a previous history of congestive heart failure (CHF).

References

    1. Zoccali, C. et al. Chronic fluid overload and mortality in ESRD. J. Am. Soc. Nephrol.28(8), 2491–2497 (2017). - PMC - PubMed
    1. Shafi, T. et al. Association of residual urine output with mortality, quality of life, and inflammation in incident hemodialysis patients: The Choices for Healthy Outcomes in Caring for End -Stage Renal Disease (CHOICE) Study. Am. J. Kidney Dis.56(2), 348–358 (2010). - PMC - PubMed
    1. Lemes, H. P. et al. Use of small doses of furosemide in chronic kidney disease patients with residual renal function undergoing hemodialysis. Clin. Exp. Nephrol.15(4), 554–9 (2011). - PubMed
    1. van Olden, R. W., van Meyel, J. J. & Gerlag, P. G. Acute and long-term effects of therapy with high-dose furosemide in chronic hemodialysis patients. Am. J. Nephrol.12(5), 351–356 (1992). - PubMed
    1. Medcalf, J. F., Harris, K. P. & Walls, J. Role of diuretics in the preservation of residual renal function in patients on continuous ambulatory peritoneal dialysis. Kidney Int.59(3), 1128–1133 (2001). - PubMed

Publication types

LinkOut - more resources